HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bowton, D. L. Search for Related Content PubMed PubMed Citation Articles by Bowton, D. L.

Nosocomial Pneumonia in the ICU—Year 2000 and Beyond^*

^* From the Department of Internal Medicine (Pulmonary and Critical Care) and Anesthesiology (Critical Care), Wake Forest University School of Medicine, Winston-Salem, NC.

Diagnostic and treatment strategies in ICU patients with ventilator-associated pneumonia (VAP) remain controversial, largely because of the paucity of well-controlled comparison trials using clinically important end points. Recent studies indicating that early appropriate antibiotic therapy significantly lowers mortality underscore the urgent need for well-designed comparative trials. When quantitatively cultured, bronchial specimens obtained by noninvasive techniques may provide clinically useful information and avoid the higher costs and risks of invasive bronchoscopic diagnostic techniques. Previous antibiotic use before onset of nosocomial pneumonia raises the likelihood of infection with highly virulent organisms, such as Pseudomonas aeruginosa and Acinetobacter sp. Thus, the empiric antibiotic regimen should be active against these Gram-negative pathogens as well as other common Gram-negative and Gram-positive causative organisms. Promising preventive modalities for nosocomial VAP include use of a semirecumbent position, endotracheal tubes that allow continuous aspiration of secretions, and heat and moisture exchangers. Rotating their standard empiric antibiotic regimens and restricting the use of third-generation cephalosporins as empiric therapy may help hospitals reduce the incidence of nosocomial pneumonia caused by resistant Gram-negative pathogens.

Key Words: antibiotic regimen • culture • ventilator-associated pneumonia

This article has been cited by other articles:

				E. H. Ibrahim, L. Tracy, C. Hill, V. J. Fraser, and M. H. Kollef The Occurrence of Ventilator-Associated Pneumonia in a Community Hospital : Risk Factors and Clinical Outcomes Chest, August 1, 2001; 120(2): 555 - 561. [Abstract] [Full Text] [PDF]

				P G Flanagan, S K Jackson, and G Findlay Diagnosis of Gram negative, ventilator associated pneumonia by assaying endotoxin in bronchial lavage fluid J. Clin. Pathol., February 1, 2001; 54(2): 107 - 110. [Abstract] [Full Text] [PDF]

				K. Stiller Physiotherapy in Intensive Care : Towards an Evidence-Based Practice Chest, December 1, 2000; 118(6): 1801 - 1813. [Full Text] [PDF]

				H. Wu, Z. Song, M. Hentzer, J. B. Andersen, A. Heydorn, K. Mathee, C. Moser, L. Eberl, S. Molin, N. Høiby, et al. Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa Microbiology, October 1, 2000; 146(10): 2481 - 2493. [Abstract] [Full Text]

				E. H. Ibrahim, S. Ward, G. Sherman, and M. H. Kollef A Comparative Analysis of Patients With Early-Onset vs Late-Onset Nosocomial Pneumonia in the ICU Setting Chest, May 1, 2000; 117(5): 1434 - 1442. [Abstract] [Full Text] [PDF]